Occurrence of cholangiocarcinoma, three years after negative seroconversion of anti-TIF1γ antibody, in a dermatomyositis patient

Eur J Dermatol. 2023 Feb 1;33(1):48-49. doi: 10.1684/ejd.2023.4414.
No abstract available

MeSH terms

  • Autoantibodies
  • Cholangiocarcinoma*
  • Dermatomyositis*
  • Humans
  • Seroconversion

Substances

  • Autoantibodies